慢性阻塞性肺疾病诊断、管理及预防全球策略：美国国立心肺血液研究所与世界卫生组织慢性阻塞性肺疾病全球倡议组织（GOLD）：执行摘要 - Suppr

Suppr

超能文献

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.

作者信息

Pauwels R A, Buist A S, Ma P, Jenkins C R, Hurd S S

出版信息

Respir Care. 2001 Aug;46(8):798-825.

PMID:11463370

Abstract

摘要

相似文献

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary.慢性阻塞性肺疾病诊断、管理及预防全球策略：美国国立心肺血液研究所与世界卫生组织慢性阻塞性肺疾病全球倡议组织（GOLD）：执行摘要

Respir Care. 2001 Aug;46(8):798-825.

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.慢性阻塞性肺疾病诊断、管理和预防全球策略：GOLD执行摘要

Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16.

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.慢性阻塞性肺疾病诊断、管理和预防全球策略。美国国立心肺血液研究所/世界卫生组织慢性阻塞性肺疾病全球倡议（GOLD）研讨会总结。

Am J Respir Crit Care Med. 2001 Apr;163(5):1256-76. doi: 10.1164/ajrccm.163.5.2101039.

[Gold strategy, early detection of COPD and need for "gold" standard of spirometry].

Pneumonol Alergol Pol. 2002;70(9-10):439-43.

Research programs of the National Heart, Lung, and Blood Institute. Bethesda, Maryland, U.S.A.

Cor Vasa. 1989;31(2):81-9.

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003.慢性阻塞性肺疾病全球诊断、管理和预防策略：2003年更新版《慢性阻塞性肺疾病全球倡议执行摘要》

COPD. 2004 Apr;1(1):105-41; discussion 103-4. doi: 10.1081/COPD-120030163.

[Differential diagnosis of bronchial asthma and chronic obstructive lung diseases. Current recommendations for the treatment of bronchial asthma and chronic obstructive lung diseases].[支气管哮喘与慢性阻塞性肺疾病的鉴别诊断。支气管哮喘与慢性阻塞性肺疾病的当前治疗建议]

Ter Arkh. 1995;67(12):66-71.

Clinical practice guidelines for chronic obstructive pulmonary disease: a review and comparison of current resources.慢性阻塞性肺疾病临床实践指南：当前资源的综述与比较

Respir Care. 2006 Mar;51(3):277-88.

Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.代谢综合征的临床管理：美国心脏协会/美国国立心肺血液研究所/美国糖尿病协会关于管理相关科学问题会议报告

Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):e19-24. doi: 10.1161/01.ATV.0000112379.88385.67.

Lung disease and asthma severity in adults with asthma: data from the Third National Health and Nutrition Examination.成人哮喘患者的肺部疾病与哮喘严重程度：来自第三次全国健康与营养检查的数据。

J Asthma. 2005 Jul-Aug;42(6):519-23. doi: 10.1081/JAS-67605.

引用本文的文献

Unravelling the Information Contained in the Single Items of the COPD Assessment Test for Different Outcomes and Smoking Status in Patients with COPD: Results from COSYCONET.解读慢性阻塞性肺疾病评估测试单项内容中关于慢性阻塞性肺疾病患者不同结局及吸烟状况的信息：COSYCONET研究结果

Int J Chron Obstruct Pulmon Dis. 2024 Dec 5;19:2629-2638. doi: 10.2147/COPD.S475112. eCollection 2024.

Start Slow and Step Up or Hit Hard, Step Down? Finding the Right Initial Therapy for Chronic Obstructive Pulmonary Disease.循序渐进还是重拳出击，是逐步减量还是一蹴而就？为慢性阻塞性肺疾病寻找合适的初始治疗方法。

Ann Am Thorac Soc. 2024 Aug;21(8):1126-1128. doi: 10.1513/AnnalsATS.202405-477ED.

Cumulative occupational exposure to gases and fumes is associated with impairment in lung function and disease-related quality of life in a German COPD patient cohort.在一个德国慢性阻塞性肺疾病（COPD）患者队列中，累积职业性接触气体和烟雾与肺功能损害及疾病相关生活质量受损有关。

Occup Environ Med. 2023 Dec 30;81(1):26-33. doi: 10.1136/oemed-2023-108908.

Bronchial rheoplasty for chronic bronchitis: 2-year results from a US feasibility study with RheOx.支气管成形术治疗慢性支气管炎：RheOx 美国可行性研究的 2 年结果。

BMJ Open Respir Res. 2023 Dec 26;10(1):e001710. doi: 10.1136/bmjresp-2023-001710.

Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET.COSYCONET 研究：COPD 患者中当前吸烟者与既往吸烟者的特征及其与 4.5 年内戒烟的关联。

Int J Chron Obstruct Pulmon Dis. 2023 Dec 6;18:2911-2923. doi: 10.2147/COPD.S436669. eCollection 2023.

Clinical factors linked to the type of respiratory medication in COPD: results from the COSYCONET cohort.与 COPD 患者呼吸药物类型相关的临床因素：COSYCONET 队列研究结果。

Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231208584. doi: 10.1177/17534666231208584.

Intracellular Drug Delivery Process of Am80-Encapsulated Lipid Nanoparticles Aiming for Alveolar Regeneration.旨在实现肺泡再生的载有Am80的脂质纳米颗粒的细胞内药物递送过程

Pharmaceuticals (Basel). 2023 Jun 4;16(6):838. doi: 10.3390/ph16060838.

Analysing the Effects of Different Types of Exercise on Dyspnoea and Fatigue in Adults through COPD-Systematic Review and Meta-Analysis of Randomised Clinical Trials.通过对随机临床试验的系统评价和荟萃分析，分析不同类型运动对慢性阻塞性肺疾病（COPD）成人患者呼吸困难和疲劳的影响。

Healthcare (Basel). 2023 May 16;11(10):1449. doi: 10.3390/healthcare11101449.

Am80-Encapsulated Lipid Nanoparticles, Developed with the Aim of Achieving Alveolar Regeneration, Have an Improvement Effect on Pulmonary Emphysema.旨在实现肺泡再生而研发的Am80包裹脂质纳米颗粒对肺气肿有改善作用。

Pharmaceutics. 2022 Dec 22;15(1):37. doi: 10.3390/pharmaceutics15010037.

Spatial Association of Environmental and Dietary Factors with COPD Deaths.环境和饮食因素与 COPD 死亡的空间关联。

Int J Chron Obstruct Pulmon Dis. 2022 Jul 26;17:1643-1650. doi: 10.2147/COPD.S364076. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验